Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01408498 · ClinicalTrials.gov registry record · NA
Study on the Effects of Exogenous Testosterone on Threat Perception and Behavioral Avoidance
A NA study of Testosterone's Effects on Threat Perception/Response, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT01408498 is a NA study of Testosterone's Effects on Threat Perception/Response that has completed, run by University of Texas at Austin. The registered enrollment target is 120 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01408498, a NA study of Testosterone's Effects on Threat Perception/Response, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The study aims to establish a clear causal link between testosterone and threat perception and behavioral responses to threat. Namely, the study focuses whether high levels of testosterone will cause an individual to exhibit increased physiological responses to threat (e.g., increased blood pressure, heart rate, and endocrine responses) and a decreased behavioral response (e.g., ignoring the threat, avoiding the threat, and postponing dealing with the threat). The threat in this study is a social threat involving public speaking, and is an outgrowth of previous research on the avoidance of health threats.
Conditions Studied
Interventions
- DRUG Testosterone
Study Locations (1)
Texas
- Seay Building - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01408498
The ClinicalTrials.gov registry entry for NCT01408498 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Testosterone's Effects on Threat Perception/Response appearing as the primary indexed condition, and to 1 intervention - of which Testosterone is the first listed.
NCT01408498 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01408498 about?
NCT01408498 is a clinical study titled "Study on the Effects of Exogenous Testosterone on Threat Perception and Behavioral Avoidance". The study aims to establish a clear causal link between testosterone and threat perception and behavioral responses to threat. Namely, the study focuses whether high levels of testosterone will cause an individual to exhibit increased physiological responses to threat (e.g., increased blood pressure...
What is the current status of trial NCT01408498?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2012-01. Estimated completion is 2012-04.
What conditions does trial NCT01408498 study?
This clinical trial studies the following conditions: Testosterone's Effects on Threat Perception/Response.
What interventions are being tested in trial NCT01408498?
The interventions under investigation include: Testosterone (DRUG).
Who is sponsoring clinical trial NCT01408498?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01408498 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.